Murine hepatic p53, Rb, and cdk inhibitory protein expression following acute 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure

Chemosphere

Volumn 34, Issue 5-7, 1997, Pages 1557-1568

  Rininger, Joseph A ^a,b   Stoffregen, Dana A ^c   Babish, John G ^a,b  

^a Cornell Technology Park ^*  (United States)

^b Department of Molecular Biology and Genetics   (United States)

^c Animal Health Diagnostic Center   (United States)

Author keywords

Cell proliferation; Cyclin dependent kinase; p16(Ink4); p21(Wafl); p27(Kipl); p53; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; PROTEIN P16; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL CYCLE; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; LIVER CELL; LIVER TUMOR; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ANIMALS; CARRIER PROTEINS; CELL CYCLE; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; FEMALE; GENES, P53; GENES, TUMOR SUPPRESSOR; LIVER; MICE; MICE, INBRED BALB C; RETINOBLASTOMA PROTEIN; TETRACHLORODIBENZODIOXIN;

ANIMALIA; MURINAE;

EID: 0030983017     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0045-6535(96)00451-1     Document Type: Conference Paper

References (45)

1. J.P. Landers and N.J. Bunce, The Ah Receptor and the Mechanism of Dioxin Toxicity, Biochem. J.276, 273-287 (1991).
2. E.C. Henry, G. Rucci and T.A. Gasiewicz, Characterization of Multiple Forms of the Ah Receptor: Comparison of Species and Tissues, Biochemistry 28, 6430-6440 (1989).
3. A. Poland, E. Glover, F.H. Ebetino and A.S. Kende, Photoaffinity Labeling of the Ah Receptor, J. Biol. Chem. 261, 6352-6365 (1986).
4. J.P. Whitlock, Genetic and Molecular Aspects of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Action, Annu. Rev. Pharmacol. Toxicol. 30, 251-277 (1990).
5. E. Enan and F. Matsumura, Evidence for a Second Pathway in the Action Mechanism of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD), Biochem. Pharmacol. 49, 249-261 (1994).
6. F. Matsumura, How Important is the Protein Phosphorylation Pathway in the Toxic Expression of Dioxin-type Chemicals? Biochem. Pharmacol. 48, 215-224 (1994).
7. D.W. Bombick, B.V. Madhukar, D.W. Brewster and F. Matsumura, TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) Causes Increases in Protein Kinases Particularly Protein Kinase C in the Hepatic Plasma Membrane of the Rat and the Guinea Pig, Biochem. Biophys. Res. Comm. 127, 296-302 (1985).
8. X. Ma, N.A. Mufti and J.G. Babish, Protein Tyrosine Phosphorylation as an Indicator of 2,3,7,8-Tetrachloro-p-Dioxin Exposure In Vivo and In Vitro, Biochem. Biophys. Res. Comm. 189, 59-65 (1992).
9. X. Ma and J.G. Babish, Acute 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Exposure Results in Enhanced Tyrosylphosphorylation and Expression of Murine Hepatic Cyclin Dependent Kinases, Biochem. Biophys. Res. Comm. 197, 1070-1077 (1993).
10. M.J. DeVito, X. Ma, J.G. Babish, M. Menache and L.S. Birnbaum, Dose-Response Relationships in Mice Following Subchronic Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, Estrogen Receptor, and Protein Tyrosine Phosphorylation, Tox. Appl. Pharm. 124, 82-90 (1994).
11. M-T. Busser and W.K. Lutz, Stimulation of DNA Synthesis in Rat and Mouse Liver by Various Tumor Promoters, Carcinogenesis 8, 1433-1437 (1987).
12. D. Wolfle, E. Becker and C. Schmutte, Growth Stimulation of Primary Rat Hepatocytes by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin, Cell Biol. Toxicol. 9, 15-31 (1993).
13. T.R. Fox, L.L. Best, S.M. Goldsworthy, J.J. Mills and T.L. Goldsworthy, Gene Expression and Cell Proliferation in Rat Liver after 2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure, Cancer Res. 53, 2265-2271 (1993).
14. J.W. Bauman, T.L. Goldsworthy, C.S. Dunn and T.R. Fox, Inhibitory Effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on Rat Hepatocyte Proliferation Induced by 2/3 Partial Hepatectomy, Cell Prolif. 28, 437-451 (1995).
15. S. Stinchcombe, A. Buchmann, K.W. Bock and M. Schwarz, Inhibition of Apoptosis During 2,3,7,8-tetrachlorodibenzo-p-dioxin Mediated Tumor Promotion in Rat Liver, Carcinogenesis 16, 1271-1275 (1995).
16. R.C. Sills, T.L. Goldsworthy and S.D. Sleight, Tumor-Promoting Effects of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Phenobarbital in Initiated Weanling Sprague-Dawley Rats: A Quantitative, Phenotypic, and ras p21 Protein Study, Toxicol. Pathol. 22, 270-281 (1994).
17. E. Farber, Cell Proliferation as a Major Risk Factor for Cancer: A Concept of Doubtful Validity, Cancer Res. 55, 3759-3762 (1995).
18. A. Kamb, Cell Cycle Regulators and Cancer, Trends Genet. 11, 136-140 (1995).
19. C. Norbury and P. Nurse, Animal cell cycles and their control, Annu. Rev. Biochem. 61, 441-470 (1992).
20. X. Grana and E.P. Reddy, Cell Cycle Control in Mammalian Cells: Role of Cyclins, Cyclin Dependent Kinases (CDKs), Growth Suppressor Genes and Cyclin-Dependent Kinase Inhibitors (CKIs), Oncogene 11, 211-219 (1995).
21. J. Pines, The Cell Cycle Kinases, Sem. Cancer Biol. 5, 305-313 (1994).
22. B. Fuchs, D. Hecker and K.H. Scheidtmann, Phosphorylation Studies on Rat p53 Using Baculovirus Expression System Manipulation of the phosphorylation state with okadaic acid and influence on DNA binding, Eur. J. Biochem. 228, 625-639 (1995).
23. C. Addison, J.R. Jenkins and H-W. Sturzbecher, The p53 Nuclear Localisation Signal is Structurally Linked to a p34cdc2 Kinase Motif, Oncogene 5, 423-426 (1990).
24. B.D. Price, L. HughesDavies and S.J. Park, CDK2 Kinase Phosphorylates Serine 315 of Human p53 In Vitro, Oncogene 11, 73-80 (1995).
25. R.A. Weinberg, The Retinoblastoma Protein and Cell Cycle Control, Cell 81, 323-330 (1995).
26. D.E. Quelle, R.A. Ashmun, G.J. Hannon, P.A. Rehberger, D. Trono, K.H. Richter, C. Walker, D. Beach, C.J. Sherr and M. Serrano, Cloning and Characterization of Murine p16Ink4a and p15Ink4b Genes, Oncogene 11, 635-645 (1995).
27. Y. Xiong, G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi and D. Beach, p21 is a Universal Inhibitor of Cyclin Kinases, Nature 366, 701-704 (1993).
28. K. Polyak, M-H. Lee, H. Erdjument-Bromage, A. Koff, J.M. Roberts, P. Tempst and J. Massague, Cloning of p27Kip1, a Cyclin-Dependent Kinase Inhibitor and a Potential Mediator of Extracellular Antimitogenic Signals, Cell 78, 59-66 (1994).
29. O. Aprelikova, Y. Xiong and E.T. Liu, Both p16 and p21 Families of Cyclin-dependent Kinase (CDK) Inhibitors Block the Phosphorylation of Cyclin-dependent Kinases by the CDK-activiating Kinase, J. Biol. Chem. 270, 18195-18197 (1995).
30. W.S. El-Deiry, J.W. Harper, P.M. O'Conner, V.E. Velculescu, C.E. Canman, J. Jackman, J.A. Pietenpol, M. Burrell, D.E. Hill, Y. Wang, K.G. Wiman, W.E. Mercer, M.B. Kastan, K.W. Kohn, S.E. Elledge, K.W. Kinzler and B. Vogelstein, Waf1/Cip1 is Induced in p53 Mediated G1 Arrest and Apoptosis, Cancer Res. 54, 1169-1174 (1994).
31. W.S. El-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler and B. Vogelstein, Waf1, A Potential Mediator of p53 Tumor Suppression, Cell 75, 817-825 (1993).
32. L.H. Hartwell and M.B. Kastan, Cell Cycle Control and Cancer, Science 266, 1821-1828 (1994).
33. T. Hunter and J. Pines, Cyclins and Cancer II: Cyclin D and CDK Inhibitors Come of Age, Cell 79, 573-582 (1994).
34. T. Hirama and H.P. Koeffler, Role of the Cyclin-Dependent Kinase Inhibitors in the Development of Cancer, Blood 86, 841-854 (1995).
35. K. Keyomarsi and A.B. Pardee, Redundent Cyclin Overexpression and Gene Amplification in Breast Cancer Cells, Proc. Natl. Acad. Sci. USA 90, 1112-1116 (1993).
36. Z.A. Khatib, H. Matsushime, M. Valentine, D.N. Shapiro, C.J. Sherr and A.T. Look, Coamplification of the CDK4 Gene with MDM2 and GLI in Human Sarcomas, Cancer Res. 53, 5535-5541 (1993).
37. J. Gong, B. Ardelt, F. Traganos and Z. Darzynkiewicz, Unscheduled Expression of Cyclin B1 and Cyclin E in Several Leukemic and Solid Tumor Cell Lines, Cancer Res. 54, 4285-4288 (1994).
38. L.A. Donehower, L.A. Godley, C.M. Aldaz, R. Pyle, Y-P. Shi, D. Pinkel, J. Gray, A. Bradley, D. Medina and H.E. Varmus, Deficiency of p53 Accelerates Mammary Tumorigenesis in Wnt-1 Transgenic Mice and Promotes Chromosomal Instability, Genes & Devel. 9, 882-895 (1995).
39. G.W. Lucier, A. Tritscher, T.L. Goldsworthy, J. Foley, G. Clark, J. Goldstein and R. Maronpot, Ovarian Hormones Enhance 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Mediated Increases in Cell Proliferation and Preneoplastic Foci in a Two-Stage Model for Rat Hepatocarcinogenesis, Cancer Res. 51, 1391-1397 (1991).
40. P. Michieli, M. Chedid, D. Lin, J.H. Pierce, W.E. Mercer and D. Givol, Induction of WAF1/CIP1 by a p53-independent Pathway, Cancer Res. 54, 3391-3395 (1995).
41. J-Y. Kato, M. Matsuoka, K. Polyak, J. Massague and C.J. Sherr, Cyclic AMP-Induced G1 Phase Arrest Mediated by an Inhibitor (p27Kip1) of Cyclin-Dependent Kinase 4 Activation, Cell 79, 487-496 (1994).
42. K. Polyak, J-Y. Kato, M.I. Solomon, C.J. Sherr, J. Massague, J.M. Roberts and A. Koff, p27Kip1, a Cyclin-CDK Inhibitor, Links Transforming Growth Factor-beta and Contact Inhibition to Cell Cycle Arrest, Genes & Devel. 8, 9-22 (1995).
43. M. Peter and I. Herskowitz, Joining the Complex: Cyclin-Dependent Kinase Inhbitory Proteins and the Cell Cycle, Cell 79, 181-184 (1994).
44. L. Liu, N.J. Lassam, J.M. Slingerland, D. Baily, D. Cole, R. Jenkins and D. Hogg, Germline p16Ink4A Mutation and Protein Dysfunction in a Family with Inherited Melanoma, Oncogene 11, 405-412 (1995).
45. A. Reymond and R. Brent, p16 Proteins from Melanoma-prone Families are Deficient in Binding to CDK4, Oncogene 11, 1173-1178 (1995).